Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

ClinicalTrials.gov ID: NCT01591902

Public ClinicalTrials.gov record NCT01591902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Placebo-controlled, Double-blind Clinical Trial to Evaluate Whether EGRIFTA® (Tesamorelin for Injection), 2 mg Once Daily SC, Increases the Risk of Development or Progression of Diabetic Retinopathy When Administered to HIV-infected Subjects With Abdominal Lipohypertrophy and Concomitant Diabetes

Study identification

NCT ID
NCT01591902
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Theratechnologies
Industry
Enrollment
129 participants

Conditions and interventions

Interventions

  • Tesamorelin Drug
  • Placebo-Control Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2012
Primary completion
Apr 30, 2018
Completion
Jul 31, 2018
Last update posted
Sep 10, 2018

2012 – 2018

United States locations

U.S. sites
24
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Southwest Center for HIV/AIDS Phoenix Arizona 85004
Spectrum Medical Group Phoenix Arizona 85012
5P21 Rand Schrader Clinic Los Angeles California 90033
University of California CARE Clinic, Los Angeles Los Angeles California 90035
Palmtree Clinical Research, Inc. Palm Springs California 92262
UCSD Antiviral Research Center San Diego California 92103
VAMC, Infectious Disease Section 111W San Francisco California 94121
Capital Medical Associates, PC Washington D.C. District of Columbia 20036
Gary J. Richmond, M.D., PA Fort Lauderdale Florida 33316
Orange County Health Department Orlando Florida 32809
Triple O Research Institute West Palm Beach Florida 33401
Rowan Tree Medical , P.A. Wilton Manors Florida 33305
Be Well Medical Center, P.C. Berkley Michigan 48072-3436
Southampton Clinical Research, Inc d.b.a. Central West Clinical Research St Louis Missouri 63108
Southampton Healthcare, Inc. St Louis Missouri 63139
South Jersey Infectious Disease Somers Point New Jersey 08244
Harold Hamm Diabetes Center at the University of Oklahoma Oklahoma City Oklahoma 73104
Fanno Creek Clinic, LLC Portland Oregon 97219
Central Texas Clinical Research Austin Texas 78705
St. Hope Foundation, Inc. Bellaire Texas 77401
Dallas VA Medical Center Dallas Texas 75216
UT Southwestern Medical Center, Atten: HIV Research Unit Dallas Texas 75235
Research Access Network Houston Texas 77098
Virginia Mason Medical Center Seattle Washington 98112

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01591902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01591902 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →